Lectin-reactive α-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors

Japanese Journal of Clinical Oncology

Volumn 32, Issue 11, 2002, Pages 472-476

  Kamoto, Toshiyuki ^a   Satomura, Shinji ^b   Yoshiki, Tatsuhiro ^c   Okada, Yusaku ^c   Henmi, Fumiyo ^b   Nishiyama, Hiroyuki ^a   Kobayashi, Takashi ^a   Terai, Akito ^a   Habuchi, Tomonori ^a   Ogawa, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b FUJIFILM Wako Pure Chemical Corporation   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

fetoprotein; Lectin reactive fetoprotein; Non seminomatous germ cell tumors

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; LECTIN; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; BINDING ASSAY; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FREEZING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID; MALE; MEASUREMENT; PATIENT MONITORING; PREDICTION; PROTEIN BLOOD LEVEL; TESTIS NONSEMINOMA CANCER; TUMOR RECURRENCE; BLOOD; CASE REPORT; MIDDLE AGED; NEOPLASM; ORCHIECTOMY; PREDICTION AND FORECASTING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TESTIS TUMOR; YOLK SAC TUMOR;

ADOLESCENT; ADULT; ALPHA-FETOPROTEINS; DIAGNOSIS, DIFFERENTIAL; ENDODERMAL SINUS TUMOR; HUMANS; LECTINS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 17144458432     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyf094     Document Type: Article

References (15)

1. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997;15:594-603.
2. Bosl GJ, Geller NL, Cirrincione C, Vogelzang NJ, Kennedy BJ, Whitmore WF, et al. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 1983;43:3403-7.
3. Toner GC, Geller NL, Tan C, Nisselbaum J, Bosl BJ. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in non-seminomatous germ cell tumors. Cancer Res 1990;50:5904-10.
4. Gerl A, Lamerz R, Clemm C, Mann K, Hartenstein R, Wilmanns W. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic non-seminomatous germ cell tumors? Clin Cancer Res 1990;2:1565-70.
5. Doherty AP, Bower M, Christmas TJ. The role of tumour markers in the diagnosis and treatment of testicular germ cell cancers. Br J Urol 1997;79:247-52.
6. Breborowicz J. Microheterogeneity of human alphafetoprotein. Tumour Biol 1988;9:3-14.
7. Saraswathi A, Malati T. Clinical relevance of alphafetoprotein microheterogeneity in alphafetoprotein-secreting tumors. Cancer Detect Prev 1994;18:447-54.
8. Taketa, K, Endo Y, Sekiya, C, Tanikawa K, Koji T, Taga H, et al. A collaborative study for the evaluation of lectin-reactive alpha-fetoprotein in early detection of hepatocellular carcinoma. Cancer Res 1993;53:5419-23.
9. Mora J, Gascon N, Tabernero JM, Germa JR, Gonzalez F. Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseases. Eur J Cancer 1995;31A:2239-42.
10. Catalona WJ, Vaitukaitis J, Fair WR. Falsely positive specific human chorionic gonadotropin assays in patients with testicular tumors: conversion to negative with testosterone administration. J Urol 1979;122:126-8.
11. Nakamura K, Imajo N, Yamagata Y, Katoh H, Fujio K, Tanaka T, et al. Liquid-phase binding assay of alpha-fetoprotein using a sulfated antibody for bound/free separation. Anal Chem 1998;70:954-7.
12. Katoh H, Nakamura K, Tanaka T, Satomura H, Matsuura S. Automatic and simultaneous analysis of lens culinaris agglutinin-reactive alphafetoprotein ratio and total alpha-fetoprotein concentration. Chem 1998;70: 2110-4.
13. Yamashiki N, Seki T, Wakabayashi M, Nakagawa T, Imamura, M, Tamai T, et al. Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma. Oncol Rep 1999;6:1229-32.
14. Morris MJ, Bosl GJ. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors. J Urol 2000;163:796-801.
15. Okuda K, Tanaka M, Kanazawa N, Nagashima J, Satomura S, Kinoshita H, et al. Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein. Int J Oncol 1999;14:265-71.